Literature DB >> 8227326

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Y Harel1, M Silva, B Giroir, A Weinberg, T B Cleary, B Beutler.   

Abstract

We have examined the hypothesis that TNF may play a pathogenetically important role in the hemolytic uremic syndrome. Specifically, we considered the possibility that shigatoxin, which eventuates this syndrome, might induce TNF biosynthesis, and/or that TNF and shigatoxin might sensitize animals, each to the toxic effects of the other agent. Shigatoxin was found to sensitize mice to the lethal effect of LPS and to the lethal effect of TNF. On the other hand, pretreatment of animals with either TNF or LPS did not noticeably sensitize mice to the lethal effect of shigatoxin. Intraperitoneal injections of shigatoxin did not induce the production of detectable quantities of TNF in the plasma of mice. When shigatoxin was injected into transgenic mice bearing a chloramphenicol acetyltransferase (CAT) reporter gene that indicates TNF synthesis, CAT activity was induced within the kidney, but not in other tissues. We therefore conclude that shigatoxin acts to induce TNF synthesis within the kidney, and at the same time increases renal sensitivity to the toxic effects of TNF. While this mouse model does not reproduce the hemolytic uremic syndrome as it occurs in humans, it does suggest that local synthesis of TNF within the kidney may contribute to renal injury induced by shigatoxin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227326      PMCID: PMC288388          DOI: 10.1172/JCI116811

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.

Authors:  T J Barrett; M E Potter; I K Wachsmuth
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

2.  Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria.

Authors:  J Levin; T E Poore; N P Zauber; R S Oser
Journal:  N Engl J Med       Date:  1970-12-10       Impact factor: 91.245

3.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice.

Authors:  T J Barrett; M E Potter; N A Strockbine
Journal:  Microb Pathog       Date:  1990-08       Impact factor: 3.738

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

Authors:  N C van de Kar; L A Monnens; M A Karmali; V W van Hinsbergh
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

8.  The relation between production of cytotoxin and clinical features in shigellosis.

Authors:  D Prado; T G Cleary; L K Pickering; C D Ericsson; A V Bartlett; H L DuPont; P C Johnson
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

9.  Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein.

Authors:  K Cseh; B Beutler
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

10.  Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice.

Authors:  T J Barrett; M E Potter; I K Wachsmuth
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

View more
  23 in total

1.  Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model.

Authors:  M S Palermo; M F Alves Rosa; N Van Rooijen; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response.

Authors:  Tatsuki Ohara; Seiichi Kojio; Ikue Taneike; Saori Nakagawa; Fumio Gondaira; Yukiko Tamura; Fumitake Gejyo; Hui-Min Zhang; Tatsuo Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2.

Authors:  Kazuhiko Hidemura; Ying Lan Zhao; Katsuki Ito; Akimasa Nakao; Yasuaki Tatsumi; Hiroaki Kanazawa; Kenzo Takagi; Michio Ohta; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7.

Authors:  E Kita; Y Yunou; T Kurioka; H Harada; S Yoshikawa; K Mikasa; N Higashi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.

Authors:  D Karpman; A Håkansson; M T Perez; C Isaksson; E Carlemalm; A Caprioli; C Svanborg
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

8.  Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Authors:  Lisa M Harrison; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.

Authors:  D Paixão-Cavalcante; M Botto; H T Cook; M C Pickering
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

10.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.

Authors:  V L Tesh; B Ramegowda; J E Samuel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.